Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 20337621.
- Also identified by DOI 10.1111/j.1365-2044.2010.06304.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is suggested that activation and differentiation of T-helper cells are required for peri-operative anti-tumor and anti-infection immunity. The present study aimed to evaluate whether propofol stimulates the activation and differentiation of these cells in patients undergoing pulmonary lobectomy for non-small-cell lung cancer. Thirty patients were randomly allocated to receive propofol or isoflurane throughout surgery. The CD4(+)CD28(+) percentage (p < 0.0001) and the ratio of interferon-gamma:interleukin-4 (p = 0.001) all increased with propofol but showed no change with isoflurane. In contrast, cortisol increased with isoflurane (p < 0.0001) but not with propofol over time (p = 0.06). We conclude that propofol promotes activation and differentiation of peripheral T-helper cells.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Isoflurane
- Lung Neoplasms
- Propofol
- T-Lymphocytes, Helper-Inducer